Alloxan Diabetes
Related entities
Findings (50)
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullThe strong association between baseline sE-selectin and incident diabetes seen in the placebo group was completely absent in both the lifestyle and metformin intervention groups, suggesting that both
Effect: null; non-significant in both ILS and metformin groups
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models
None
nullNeither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.
Effect: null; non-significant in all groups and all models